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ABSTRACT
Chemical investigation of the methanol extract of the leaves of Tectona grandis led to the isolation of one new anthraquinone derivative, grandiquinone A (3-acetoxy-8-hydroxy-2-methylanthraquinone) (1), along with nine known compounds: 5,8-dihydroxy-2-methylanthraquinone (2), hydroxysesamone (3), 3-hydroxy-2-methylanthraquinone (4), quinizarine (5), betulinic acid (6), ursolic acid (7), tectograndone (8), corosolic acid (9) and sitosterol 3-O-β-d-glucopyranoside (10). Compounds 2 and 3 were isolated for the first time from the leaves of this plant, while 5 has never been reported from the genus Tectona. Hydroxysesamone (3) and tectograndone (8) were subjected to cyclisation and acetylation reactions to afford two hemisynthetic derivatives, 6,9-dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11) and acetyltectograndone (12) respectively, which are reported here for the first time. The ethyl acetate-soluble portion, some of the isolated compounds and hemisynthetic derivatives were evaluated for their antiplasmodial activity against the multidrug-resistant Dd2 strain of Plasmodium falciparum. Compound 3 showed a prominent activity, while 2, 8, 9, 11 and 12 showed significant in vitro anti-malarial activity. Compound 1 was weakly active in this test. The structures of the compounds were elucidated by spectroscopic methods and comparison of the data with the literature.
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1. Introduction





Fig. 1. Chemical structures of compounds isolated from T. grandis (1-10) and of cyclised and acetylated derivatives (11-12).


Table 1 1H and 13C NMR data for compound 1 (500 and 125 MHz, in CDCl3), δ in ppm, J in Hz.
Position	δH	δC	HMBC (H→C)
1	8.20, 1H, s	130.5	C-3, C-9, C-9a
2	-	137.9	-
3	-	154.4	-
4	7.94, 1H, s	121.1	C-2, C-3, C-4a, C-10
4a	-	130.8	
5	7.82, 1H, dd (12.0, 6.0)	119.6	C-6, C-7
6	7.67, 1H, t (12.0)	136.7	C-8, C-lOa














Fig. 2. HMBC (1H-13C) correlations for 1.


2. Results and discussion
The ethyl acetate-soluble fraction of the leaves of T. grandis was fractionated by silica gel column chromatography followed by gel permeation over Sephadex LH-20 to afford the new anthraquinone derivative, grandiquinone A (1), along with the known 5,8-dihydroxy-2-methylanthraquinone (2) (Hua et al., 2004), hydroxysesamone (3) (Hasan et al., 2001), 3-hydroxy-2-methylanthraquinone (4) pa Silva et al., 2008), quinizarine (5) (Hua et al., 2004), betulinic acid (6) (Shukla et al., 2010), ursolic acid (7) (Shukla et al., 2010), tectograndone (8) (Aguinaldo et al., 1993), corosolic acid (9) (Mohammed et al., 1991), and sitosterol 3-O-β-d-glucopyranoside (10) (Singh et al., 2010). Two hemisynthetic compounds, 6,9-dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g] chromene-5,10-dione (11) and acetyl tectograndone (12) were newly reported. Structures of the compounds (Fig. 1) were elucidated by 1D and 2D NMR spectroscopy, ESI and EI-MS and comparison of the data with those reported in the literature (Fig. 2).







Table 2 Antiplasmodial activities of isolated and modified compounds from the ethyl acetate-soluble fraction of the leaves of T. grandis.
Substance	IC50 on Dd2 PlasmodiumfalciparumIC50 (µg/mL)	CC50 on LLC-MK2	SI LLC-MK2/Dd2
Grandiquinone A (1)	6.24 ± 1.21	ND	ND
5,8-Dihydroxy-2-methylanthraquinone (2)	1.63 ± 0.04	125.24 ± 25.45	76.83
Hydroxysesamone (3)	0.82 ± 0.06	97.66 ± 52.96	119.1
Tectograndone (8)	1.57± 0.17	77.14 ± 21.40	49.13
Corosolic acid (9)	1.61 ± 0.14	161.96 ± 73.97	100.6
6,9-Dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11)	1.24 ± 0.43	73.94 ± 6.14	56.63
Acetyltectograndone (12)	1.06 ± 0.39	134.13 ± 53.96	126.54
Ethyl acetate-soluble fraction	35.15 ± 3.39	>1000	>28.57
Chloroquine	0.100 ± 0.042	ND	ND
IC50, drug concentration causing 50% inhibition of parasite growth and multiplication; CC50, cytotoxic concentration causing 50% inhibition of mammalian cell growth and multiplication; SI, selectivity index=CC50/IC50. IC50 and CC50 values are means and standard deviations obtained from six different replicate tests.
Dd2 is a chloroquine resistant strain of P. falciparum. Crude extract TGFEA (ethylacetate-soluble fraction) was considered weakly active (for crude extracts, IC50 < 5 µg/mL is considered very active, 5 µg/mL ≤ IC50 ≤ 10 µg/mL as active, 10 µg/mL ≤ IC50 ≤ 25 µg/mL as moderately active, 25 µg/mL ≤ IC50 ≤ 50 µg/mL as weakly active and IC50 > 50 µg/mL as inactive.
Compounds with IC50 < 0.06 µg/mL were considered as very active, those with 0.06 ≤ IC50 ≤ 5 µg/mL as active, 5 µg/mL ≤ IC50 ≤ 10 µg/mL as weakly active while those with IC50 > 10 µg/mL were considered as inactive (Mahmoudi et al., 2006).
Selective index (SI) = CC50 on LLC-MK2 cells/IC50 on P. falciparum. CC50< 1.0 µg/mL (highly toxic); CC50 1.0-10.0 µg/mL (moderately toxic);.
CC50 10.0-30.0 µg/mL (mildly toxic) and CC50 > 30 µg/mL (non-toxic) (Malebo et al., 2009). SI > 10 (non- toxic) and SI < 10 (toxic) (Sarr et al., 2011).

In addition to 3-acetyltectone (grandiquinone A) (1), nine known compounds (2-10), were isolated. To the best of our knowledge, 5,8-dihydroxy-2-methylanthraquinone (2), hydroxysesamone (3) and quinizarine (5) were reported for the first time from T. grandis. Quinizarine (5), a well known synthetic hydroxyanthraquinone, has been so far isolated only from Cassia genus. It is then reported for the first time in the genus Tectona (Lee, 2003; Yang et al., 2003). The cyclisation of hydroxysesamone (3) and acetylation of tectograndone (8) gave two new derivatives, 6,9-dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11) and acetyltectograndone (12), respectively. Their structures were established by comparison of their NMR data with those of related compounds reported in the literature (Aguinaldo et al., 1993; Hasan et al., 2001; Fujiwara et al., 1998; Matsumoto et al., 1985).
The ethyl acetate-soluble fraction, five of the isolated compounds (1-3, 8, 9) and hemisynthetic derivatives 11 and 12 were tested for their antiplasmodial activity against the multidrug-resistant Dd2 strain of Plasmodium falciparum and their effects on the LLC-MK2 monkey kidney epithelial cell line. The antimalarial profiles as well as the selectivity in the biological activity are presented in Table 2. Despite its relatively low antiplasmodial activity (IC50 of 35.15 µg/mL), this extract was shown to contain promising antimalarial constituents, among which hydroxysesamone (3) was the most prominent, with an IC50 of 0.82 µg/mL 5,8-Dihydroxy-2-methylanthraquinone (2), tectograndone (8), and corosolic acid (9) exhibited a significant activity (1.57 µg/ mL ≤ IC50 ≤ 1.63 µg/mL), while grandiquinone A (1) showed a weak activity (IC50 6.24 µg/mL). Interestingly, the hemisynthetic derivatives  6,9-dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11) and tectograndone acetate (12) also displayed significant activity with the IC50 values of 1.24 µg/mL and 1.06 µg/mL, respectively. Natural and synthetic quinones have shown significant antimalarial activity against chloroquine-resistant Plasmodium parasites (Sittie et al., 1999; Eyong et al., 2006; Fotie, 2006; Osman et al., 2010). Previous structure-activity studies demonstrated that an aldehyde group at C-2 and a phenolic hydroxy group at C-3 on the skeleton enhance the activity of anthraquinones against the growth of P. falciparum (Sittie et al., 1999; Osman et al., 2010). The presence of a methyl group at C-2 together with phenolic hydroxy group at C-3 seems to be also important for this activity. 3-Hydroxy-2-methylanthraquinone (4) for example exhibited strong inhibition against the 3D7 strain of P. falciparum with an IC50 value of 0.34 µM (Osman et al., 2010). Newbouldiaquinone A, a naphtoquinone-anthraquinone coupled via an ether bridge than a C-C bond was reported to display moderate antimalarial activity (Eyong et al., 2006). It is well known that lapachol, a hydroxyprenylated naphtoquinone structurally related to hydroxysesamone (3), is highly effective against the prevention of P. falciparium (Andrade-Neto et al., 2004). Our results showed that the product of cyclisation, 6,9-dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11) was about 2 times less active than its precursor 3. The prenyl group present in ring B of 3 is likely to be responsible for the anti-malarial property of this molecule. Thus, cyclisation of the isoprenyl group may have led to a drastic reduction of the activity of 11. Further investigations are therefore highly needed to identify the target and fully elucidate the mechanism of action of this compound. With regards to their specificity, all the six compounds tested showed no significant cytotoxicity with their CC50 values ranging from 73.94 to 161.96 µg/mL They all also proved to be highly selective for the Plasmodium parasite with SI ranging from 46 to 126. These cytotoxicity values obtained from the monkey kidney cells could suggest their potential as safer therapy and therefore their potential as lead anti-malarial candidates.

3. Experimental
3.1.  General experimental procedures
Melting points of the isolated compounds were determined using an Electrothermal IA9000 Series digital melting point apparatus (Bibby scientific, Great Britain). MS detection was carried out using Micromass ESI-Q-TOF II instrument using ESI ionization in the positive mode (Waters). EIMS spectra were recorded on a Finnigan MAT 95 spectrometer (70 eV) with perfluorkerosine as reference substance for HR-ESI-TOF-MS (Japan). IR spectra were recorded on a Shimadzu FTIR-8400S spectrophotometer (Japan). UV spectra were recorded on a Shimadzu UV-160A spectrometer (Japan) in absolute ethanol (Scharlau) and alkaline ethanol. The NMR spectra were measured on Bruker 300 MHz, 500 MHz and 600 MHz NMR Avance II spectrometers equipped with cryoprobe, with TMS as an internal reference. Chemical shifts were recorded in δ (ppm) and the coupling constants (J) are in hertz. Silica gel 60 F254 (70-230; Merck; Darmstadt, Germany) was used for column chromatography. Precoated silica gel Kieselgel 60 F254 plates (0.25 mm thick) were used for TLC, and spots detected by spraying with 50% H2SO4 followed by heating at 100 °C.
3.2.  Plant material
The leaves of T. grandis were collected at Limbe, South-West Region of Cameroon in August 2009. Authentification was performed by Mr Victor Nana who compared it with a voucher specimen (No. 61993 HNC) at the Cameroon National Herbarium, Yaoundé.
3.3.  Extraction and isolation
Dried leaves of T. grandis (3 kg) were extracted with methanol (25 L) for 72 h at room temperature to yield a crude extract ( 117 g) after evaporation under vacuum. This extract was dissolved in H2O (1 L) and extracted with EtOAc (3 x 1 L) to give an EtOAc-soluble fraction (72 g) after evaporation under vacuum. Seventy grams of this fraction were subjected to silica gel column chromatography eluted with n-hexane-EtOAc (10:0, 95:5, 90:10, 8:2,1:1, 0:10) and EtOAc-MeOH (9:1, 8:2, 1:1, 0:10) to afford 28 fractions of 600 mL each. These fractions were combined on the basis of their TLC profiles (using mixtures of n-hexane-EtOAc 85:15, 70:30,30:70) to give five major fractions A-E (A: 1-11; B: 12-14; C: 15-17; D: 18-22; E: 23-28). Fraction A (6 g) was subjected to column chromatography over silica gel with a gradient of n-hexane-EtOAc to give compounds 2 (10 mg) and 3 (40 mg). Fraction B (20 g) was separated by column chromatography over silica gel using n-hexane-EtOAc mixtures of increasing polarity to yield compound 1 (2 mg). Fraction C (10 g) was subjected to column chromatography on Sephadex LH-20 using n-hexane-dichloromethane-methanol (7:4:0.5) to afford four subfractions (C1-C4). Subfractions Cl (0.5 g) and C2 (1.0 g) were further chromatographed on silica gel columns, eluting with mixtures of n-hexane-EtOAc (100:0, 95:5, 90:0, and 80:20) to yield compounds 4 (5 mg) and 6 (50 mg), respectively. The mixture crystallized from subfraction C3 (52.5 mg) was purified by column chromatography on silica gel, eluting with n-hexane-EtOAc (9:1) to give compound 7 (10 mg). Fraction D (13.5 g) was subjected to silica gel column chromatography eluted with n-hexane-EtOAc mixtures of increasing polarity to afford five subfractions (D1-D5). Successive chromatography of sub fraction D2 (100 mg) over Sephadex LH-20 (n-hexane-dichloromethane-methanol, 7:4:0.5) and silica gel (n-hexane-CH2Cl2-Me2CO, 10:7:3.5) yielded 9 (15 mg). Compounds 5 (3 mg) and 8 (72 mg) were obtained from the purification of subfraction D5 (5.0 g) over silica gel using n-hexane-CH2Cl2 (6:4) as solvent system. Fraction E (1 g) was chromatographed over a silica gel column eluting with a gradient of CH2Cl2-EtOAc (10:0, 95:5, 90:10, 80:20, 70:30, 1:1, 0:10) to yield 10 (30 mg).
3.4. Compound 1
3.4.1.  3-Acetoxy-8-hydroxy-2-methylanthraquinone (1)
Orange powder; mp 167-168 °C; UV(MeOH), λmax(log ε): 216 (3.11), 226 (3.05), 262 (3.51), 336 (2.19), 407 (2.49) nm; IR (KBr) 3047, 2956, 1757, 1670, 1635, 1596, 1299 cm-1; 1H and 13C NMR (CDCl3, 500 and 125 MHz resp.) see Table 1; HR-ESI-MS (pos. mode) m/z 297.0762 [M+H]+ (calcd. for C17H13O5: 297.0763); ESI-MS (pos. mode) m/z (rel. int.) 255 [M-OCOCH3]+, 100), 297 ([M+H]+, 94), 298 ([M+2H]+, 23), 319 ([M+Na]+, 17).
A solution of hydroxysesamone (3) (18 mg) in formic acid (2.0 mL) was heated on a steam-bath for 2 h. The mixture was poured into ice and the solid formed was crystallized from n-hexane-AcOEt to give 11 as red amorphous powder (15 mg).
Tectograndone (8) (30 mg) was dissolved in pyridine (3 mL) and acetic anhydride (3 mL) and stirred at room temperature for 24 h. Ten milliliters of water were added to the mixture and stirred for 30 min. Extraction with CH2Cl2 and purification over a silica gel column with n-hexane-AcOEt (7:3) as solvent gave acetyltectograndone (12) (10 mg).
3.4.2.  6,9-Dihydroxy-2,2-(dimethyldihydropyrano)-3,4-dihydro-2H-benzo[g]chromene-5,10-dione (11)
Red powder; mp 155-156 °C; IR (KBr) 2972, 2947, 1600, 1670, 1461, 1288, 829 cm-1; 1H NMR (600 MHz, CDCl3): δ (ppm) 12.75 (1H, s, 6-OH), 12.25 (1H, s, 9-OH), 7.20 (1H, d, J = 9.3, H-8), 7.15 (1H, d, J = 9.3, H-7), 2.61 (2H, t, J = 13.0, H-4), 1.83 (2H, t, J = 13.0, H-3), 1.44 (6H, s, 11-CH3/12-CH3); 13C NMR (150 MHz, CDCl3): S (ppm) 187.7 (C-10), 182.7 (C-5), 157.8 (C-9), 156.6 (C-6), 155.1 (C-10a), 130.1 (C-8), 127.9 (C-7), 120.8 (C-4a), 111.4 (C-5a), 110.6 (C-9a), 78.7 (C-2), 31.2 (C-3), 26.5 (C-11/C-12), 16.4(C-4); ESI-MSm/z(rel. int): 297 [M+Na]+ (100), 441 (9), 571 [2M+Na]+ (2).
3.4.3.  Acetyltectograndone (12)
Amorphous solid; 1H NMR (600 MHz, CDCl3): δ (ppm) 13.79 (1H, s, 5-OH), 12.97 (1H, s, 12-OH), 12.54 (1H, s, 8'-OH), 11.60 (1H, s, 5'-OH), 8.28 (1H, s, H-7), 7.68 (1H, d, J = 9.6, H-6'), 7.31 (1H, s, H-9), 7.25 (1H, d, J = 9.6, H-7'), 6.74 (1H, d, J = 10.0, H-4), 5.75 (1H, d, J = 10.0, H-3), 2.52 (3H, s, 8-Me), 2.21 (3H, s, 2'-CH3OCO), 1.53 (3H, s, 2-Me), 1.52 (3H, s, 2-Me); 13C NMR(150 MHz, CDCl3): S 187.5 (C-4'), 187.0 (C-1'), 185.0 (C-6), 182.7 (C-11), 168.0 (OCOCH3), 158.0 (C-8'), 157.6 (C-5'), 156.1 (C-5), 151.4 (C-12a), 149.3 (C-12), 145.4 (C-8), 138.3 (C-9), 135.5 (C-2'), 132.5 (C-10), 132.0 (C-3), 131.9 (C-6'), 131.1 (C-10a), 129.9 (C-7), 128.0 (C-7'), 126.4 (C-3'), 126.1 (C-6a), 116.8 (C-4a), 115.4 (C-4), 112.9 (C-11a), 111.0 (C-4'a), 79.4 (C-2), 28.7 (2-CH3), 28.6 (2-CH3), 22.1 (8-CH3); ESI-MS m/z (rel. int): 316 (5), 413 (100), 441 (20), 585 (5), 605 (15), 631 (10), 647 (46), 669 (5), 803 (81).
3.5.  In vitro antiplasmodial assay
The culture of P. falciparum strains was carried out as previously described by using the method of Trager and Jensen with some modifications (Zofou et al., 2011b). The ethyl acetate extract, compounds 1, 2, 3, 8, 9, 11 and 12 were evaluated in vitro for their activity against the multidrug-resistant Dd2 strain of P. falciparum. Drug sensitivity assay was carried out using the parasite lactate dehydrogenase assay, as previously reported (Zofou et al., 2011b).
3.6.  Cytotoxicity test for crude extract and compounds
The cytotoxicity of pure compounds was investigated against LLC-MK2 (ATCC, USA) monkey kidney epithelial cells according to the procedure described (Malebo et al., 2009; Mosmann, 1983; Zofou et al., 2011b).
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